Business & Finance News Today | 2 Min News | The Daily News Now!

Gorilla just unleashed its first quarter numbers—and it’s not just another earnings report. CEO Jayesh Chandan declared this a pivotal shift: from turnaround to full-scale AI infrastructure expansion. Revenue jumped 55% YoY to $28.2M, and they turned operating cash flow positive—despite hefty upfront costs. The company is now aggressively building data centers, securing land across Asia, and deploying GPU power, moving beyond security to become a regional AI infrastructure powerhouse. Projects are live in India and Thailand, with colocation in Jakarta and Batam, and a strategic partnership with Yotta in India. Leadership admits the accounting noise is tough now—but they’re betting big on long-term value, choosing to absorb costs when their stock is low rather than later when it’s high. This isn’t just growth—it’s a bold, physical, global buildout designed to dominate the AI infrastructure future.

Support the show:
Get a discount at https://solipillow.com/discount/dnn.

Advertise on DNN:
advertise@thednn.ai

This is an automated, high-level news summary based on public reporting.
Report issues to feedback@thednn.ai.

View sources & latest updates:
https://sources.thednn.ai/0b58741b0fadafdf

Wall Street giants are taking notice as crypto platforms dominate 24/7 perpetual futures trading, forcing regulators to act. NYSE’s Jeffrey Sprecher admits they’re not scared—just learning—and pushing for U.S. exchanges to offer similar products. Just days after his comments, the CFTC greenlit Kalshi for Bitcoin perpetuals, while Coinbase opened doors for U.S. institutions to access global crypto derivatives. Even SpaceX’s potential IPO is being priced on crypto markets, showing how crypto is reshaping traditional finance. The message is clear: demand is real, and regulators are finally catching up.

Support the show:
Get a discount at https://solipillow.com/discount/dnn.

Advertise on DNN:
advertise@thednn.ai

This is an automated, high-level news summary based on public reporting.
Report issues to feedback@thednn.ai.

View sources & latest updates:
https://sources.thednn.ai/6480632e97422c28

Healthcare’s post-COVID rebound is lagging behind the market, with sluggish growth and rising competition making some stocks risky bets. Omnicell’s automation efforts haven’t translated to strong sales or profits, Jazz’s margins and earnings are shrinking despite revenue gains, and The Pennant Group’s thin cash flow and high debt leave little room for error—all signaling caution for investors.

Support the show:
Get a discount at https://solipillow.com/discount/dnn.

Advertise on DNN:
advertise@thednn.ai

This is an automated, high-level news summary based on public reporting.
Report issues to feedback@thednn.ai.

View sources & latest updates:
https://sources.thednn.ai/3970628e9489c963

CoStar’s big move: $800M all-cash buy of Zonda, the residential real estate data powerhouse, to dominate the homebuilder market and revamp its residential offerings. Zonda’s lot-level data, two thriving marketplaces, and strong client retention give CoStar a major boost — especially as they rebound from last year’s losses with a 100% EBITDA jump and a $3M Q1 profit.

Support the show:
Get a discount at https://solipillow.com/discount/dnn.

Advertise on DNN:
advertise@thednn.ai

This is an automated, high-level news summary based on public reporting.
Report issues to feedback@thednn.ai.

View sources & latest updates:
https://sources.thednn.ai/d2ca9416fb3e4883

Dell just shattered expectations with a jaw-dropping Q1 earnings surge—adjusted EPS up 214% YoY and revenue nearing $44 billion—driven by explosive AI server demand. The company now forecasts $60 billion in AI server revenue for the year and raised its full-year revenue guidance to $167 billion, a 47% jump from last year. Analysts are stunned, calling it one of the most impressive hardware quarters ever. While Nvidia steals the spotlight, Dell is quietly building the backbone of AI infrastructure, assembling servers that integrate GPUs, memory, and storage. With stock up over 220% this year and a $51 billion AI server backlog, demand far outpaces supply—and Dell expects that momentum to last through 2025. Should you buy? The valuation is high, but this AI supercycle may differ from past cycles. Proceed cautiously: start small, add gradually, and prepare for volatility.

Support the show:
Get a discount at https://solipillow.com/discount/dnn.

Advertise on DNN:
advertise@thednn.ai

This is an automated, high-level news summary based on public reporting.
Report issues to feedback@thednn.ai.

View sources & latest updates:
https://sources.thednn.ai/f50285d96228b752

If you’ve got a chronic condition and are planning a trip, travel insurance might not cover you—unless you get a preexisting condition waiver. Most policies deny claims if your illness is linked to a condition you had before buying the policy, even if you haven’t been officially diagnosed. Travel insurers look back up to 180 days for symptoms a reasonable person would’ve treated. To protect yourself, buy a policy with a waiver within 14–21 days of your trip deposit and insure the full nonrefundable cost. Note: mental health and substance abuse issues are often excluded. Stay prepared—call emergency services immediately if something goes wrong.

Support the show:
Get a discount at https://solipillow.com/discount/dnn.

Advertise on DNN:
advertise@thednn.ai

This is an automated, high-level news summary based on public reporting.
Report issues to feedback@thednn.ai.

View sources & latest updates:
https://sources.thednn.ai/ff0816133e9dfa32

BioLineRx is making major strides with GLIX1, a groundbreaking drug targeting glioblastoma—one of the deadliest brain cancers—with its first human trial now underway at NYU Langone and two other top academic centers. Designed to cross the blood-brain barrier and disrupt DNA repair in tumors, GLIX1 showed dramatic tumor growth suppression in animal models—even in treatment-resistant cases. With a median survival of just 12-18 months for glioblastoma patients and no major advances in treatment in over two decades, this could be a game-changer. Full trial results are expected by 2027, and BioLineRx is also showcasing strong preclinical data at major oncology conferences, hinting at broader applications. Meanwhile, their other pipeline assets—motixafortide for pancreatic cancer and sickle cell disease, plus rising royalties from APHEXDA—are fueling momentum and positioning the company for significant growth in a high-demand, underserved market.

Support the show:
Get a discount at https://solipillow.com/discount/dnn.

Advertise on DNN:
advertise@thednn.ai

This is an automated, high-level news summary based on public reporting.
Report issues to feedback@thednn.ai.

View sources & latest updates:
https://sources.thednn.ai/2f61740f012daf81

AI costs are skyrocketing, forcing CEOs to choose between funding cutting-edge models or keeping human employees — a painful trade-off the market hasn’t fully reckoned with. Annual AI budgets are vanishing in months as prices double with each new model, making AI more expensive than people for the first time. Most companies still overuse pricey models for simple tasks, wasting money — but switching to cheaper alternatives could slash costs tenfold. The real fix? Don’t use the fanciest AI for everything — sometimes, the difference between top-tier and mid-tier models is barely noticeable.

Support the show:
Get a discount at https://solipillow.com/discount/dnn.

Advertise on DNN:
advertise@thednn.ai

This is an automated, high-level news summary based on public reporting.
Report issues to feedback@thednn.ai.

View sources & latest updates:
https://sources.thednn.ai/d6227fd0903d82b0

Super Micro’s stock surged 10% today not because of its own news, but thanks to Dell’s blockbuster earnings—where AI-driven demand exploded, fueling optimism across the entire server market. Dell’s sales jumped 88% YoY, profits soared 282%, and 56% of its revenue came from AI orders. The COO confirmed the AI boom is far from over, giving investors confidence that the trend is sustainable—and that’s why Super Micro is riding the wave, even as rivals shine. Meanwhile, analysts are pointing to other high-growth stocks, suggesting the AI frenzy may just be the tip of the iceberg.

Support the show:
Get a discount at https://solipillow.com/discount/dnn.

Advertise on DNN:
advertise@thednn.ai

This is an automated, high-level news summary based on public reporting.
Report issues to feedback@thednn.ai.

View sources & latest updates:
https://sources.thednn.ai/27c4aa3cfd1e8410

Trump’s looming decision on a fragile Iran ceasefire has markets on edge, as optimism from earlier talks clashes with lingering uncertainty. With nuclear ambitions and Hormuz access still unresolved, conflicting statements from U.S. officials and Iran’s skepticism keep traders guessing—especially as Trump’s history of weekend surprises adds to the suspense. A 60-day ceasefire extension and ongoing nuclear talks hang in the balance, pending his final call, making every hour feel like a ticking clock for global stability.

Support the show:
Get a discount at https://solipillow.com/discount/dnn.

Advertise on DNN:
advertise@thednn.ai

This is an automated, high-level news summary based on public reporting.
Report issues to feedback@thednn.ai.

View sources & latest updates:
https://sources.thednn.ai/712873abcb8d0193